NEUROCRINE - Trademark Details
Status: 732 - Third Extension - Granted
Image for trademark with serial number 88155301
Serial Number
88155301
Word Mark
NEUROCRINE
Status
732 - Third Extension - Granted
Status Date
2021-11-19
Filing Date
2018-10-15
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2020-03-24
Attorney Name
Allison Strickland Ricketts
Law Office Assigned Location Code
M40
Employee Name
FOX III, LYAL L
Statements
Goods and Services
Pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; Pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; Pharmaceutical preparations for human use for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of endocrine diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of hormonal diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of genetic diseases, disorders and conditions
Pseudo Mark
NEURO CRINE; NEURO ENDOCRINE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-10-25
Primary Code
005
Current Trademark Owners
Party Name
Neurocrine Biosciences, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Neurocrine Biosciences, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Neurocrine Biosciences, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Allison Strickland Ricketts
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0085047
Original Filing Date USPTO
2019-04-12
International Status Code
401
Madrid History Events
DateCodeDescription
2019-04-12INAPWINTERNATIONAL APPLICATION WITHDRAWN
2019-04-22INAPWINTERNATIONAL APPLICATION WITHDRAWN
Entry Number
2
Reference Number
A0085061
Original Filing Date USPTO
2019-04-12
International Registration Number
1468022
International Registration Date
2019-04-12
International Status Code
480
International Renewal Date
2029-04-12
Madrid History Events
DateCodeDescription
2019-09-12CBNARCEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE
2019-04-12NEWAPNEW APPLICATION FOR IR RECEIVED
2019-04-23MCERTMANUALLY CERTIFIED
2019-04-23APPSTIR CERTIFIED AND SENT TO IB
2019-10-02CBNARCEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE
2019-05-23CREATAPPLICATION FOR IR REGISTERED BY IB
2019-08-28CBPCPPARTIAL CEASING OF EFFECT TO BE PROCESSED
2019-08-28CBPCPPARTIAL CEASING OF EFFECT TO BE PROCESSED
Trademark Events
Event DateEvent Description
2018-10-18NEW APPLICATION ENTERED IN TRAM
2018-10-25NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-01-24ASSIGNED TO EXAMINER
2019-01-31PRIORITY ACTION WRITTEN
2019-01-31PRIORITY ACTION E-MAILED
2019-01-31NOTIFICATION OF PRIORITY ACTION E-MAILED
2019-07-24TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-07-24CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-07-25TEAS/EMAIL CORRESPONDENCE ENTERED
2019-08-15FINAL REFUSAL WRITTEN
2019-08-15FINAL REFUSAL E-MAILED
2019-08-15NOTIFICATION OF FINAL REFUSAL EMAILED
2020-02-11EXAMINERS AMENDMENT -WRITTEN
2020-02-11EXAMINERS AMENDMENT E-MAILED
2020-02-11NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2020-02-11EXAMINER'S AMENDMENT ENTERED
2020-02-11APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-18ASSIGNED TO LIE
2020-03-04NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-03-24PUBLISHED FOR OPPOSITION
2020-03-24OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-05-19NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-10-28TEAS EXTENSION RECEIVED
2020-10-28EXTENSION 1 FILED
2020-10-28EXTENSION 1 GRANTED
2020-10-30NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-05-19TEAS EXTENSION RECEIVED
2021-05-24ASSIGNED TO EXAMINER
2021-05-27CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-05-19EXTENSION 2 FILED
2021-05-27EXTENSION 2 GRANTED
2021-05-28NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-11-19TEAS EXTENSION RECEIVED
2021-11-19EXTENSION 3 FILED
2021-11-19EXTENSION 3 GRANTED
2021-11-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED